Doxil/Caelyx |
PEGylated liposomal formulation of doxorubicin |
Various Cancers |
1995 |
Ontak |
Denileukin diftitox |
Cutaneous T-cell lymphoma |
1999 |
Visudyne |
liposomal formulation of verteporfin |
Wet
age-related macular degeneration |
2000 |
Eligard |
Leuprolide acetate and PLGH polymer formulation |
Advanced prostate cancer |
2002 |
Estrasorb™ |
Micellar Estradiol |
Vasomotor symptoms in
Menopause |
2003 |
Macugen |
PEG-anti-VEGF aptamer |
Neovascular age-related
macular degeneration as a cause of blindness in aged people |
2004 |
Abraxane® |
Albumin-bound paclitaxelnanoparticles |
Breast
Cancer |
2005 |
Renvela |
Sevelamer carbonate; and Sevelamer HCl |
Chronic
kidney disease |
2007 |
Cimzia® |
Certolizumab pegol |
Rheumatoid arthritis |
2009 |
Abraxane® |
Albumin-bound paclitaxelnanoparticles |
Pancreatic
Cancer |
2013 |
Onivyde® |
Liposomal Irinotecan |
Pancreatic Cancer |
2015 |
Zilretta |
Triamcinolone acetonide |
Osteoarthritis knee pain |
2017 |